147
Views
6
CrossRef citations to date
0
Altmetric
Articles

The effect of hypertension on cardiac structure and function in different types of hypertrophic cardiomyopathy: A single-center retrospective study

, , &
Pages 359-365 | Received 13 Mar 2018, Accepted 05 Jun 2018, Published online: 09 Jul 2018

References

  • Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly - NEJM. N Engl J Med. 1987;38:567.
  • Karam R, Lever HM, Healy BP. Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol. 1989;13:580–84.
  • Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary. J Thorac Cardiovasc Surg. 2011;142:1303–38.
  • Papadopoulos DP, Papademetriou V. Hypertrophic and hypertensive hypertrophic cardiomyopathy–a true association?. Angiology. 2010;61:92–99.
  • Argulian E, Messerli FH, Aziz EF, Winson G, Agarwal V, Kaddaha F, Kim B, Sherrid MV. Antihypertensive therapy in hypertrophic cardiomyopathy. Am J Cardiol. 2013;111:1040–45.
  • Rodrigues JC, Rohan S, Ghosh DA, Harries I, Lawton CB, Ratcliffe LE, Burchell AE, Hart EC, Hamilton MCK, Paton JFR, et al. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm. Eur Radiol. 2016;27:1125–35.
  • Ong KC, Geske JB, Hebl VB, Nishimura RA, Schaff HV, Ackerman MJ, Klarich KW, Siontis KC, Coutinho T, Dearani JA, et al. Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy[J]. Eur Heart J Cardiovasc Imaging. 2016;17:604–10.
  • Musumeci MB, Mastromarino V, Casenghi M, Tini G, Francia P, Maruotti A, Romaniello A, Magrì D, Lillo R, Adduci C, et al. Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy. Int J Cardiol. 2017;248:326–32.
  • Kao YC, Lee MF, Mao CT, Chen W-S, Yang N-I, Cherng W-J, Hung M-J. Differences of left ventricular systolic deformation in hypertensive patients with and without apical hypertrophic cardiomyopathy. Cardiovasc Ultrasound. 2013;11:40.
  • Members ATF, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.
  • Doi YL, Deanfield JE, Mckenna WJ, Dargie HJ, Oakley CM, Goodwin JF. Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy. Br Heart J. 1980;44:395–400.
  • Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, Iiyama T, Kumagai N, Tanioka K, Yamasaki N, et al. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;62:1252–59.
  • Dimitrow PP, Czarnecka D, Kawecka-Jaszcz K, Dubiel JS. The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2003;88:11–16.
  • Dimitrow PP, Czarnecka D, Strojny JA, Kawecka-Jaszcz K, Dubiel JS. Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2001;77:43–48.
  • Aslam F, Haque A, Foody J, Shirani J. The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience. J Clin Hypertens. 2010;12:240–45.
  • Nadruz W. Myocardial remodeling in hypertension. J Hum Hypertens. 2015;29:1–6.
  • Dehlin HM, Manteufel EJ, Monroe AL, Reimer MH, Levick SP. Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension. Int J Cardiol. 2013;168:4643–51.
  • Tarazi RC, Levy MN. Cardiac responses to increased afterload State-Of-The-Art Review. Hypertension. 1982;4:8–18.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
  • Jacoby DL, Depasquale EC, Mckenna WJ. Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment. Can Med Assoc J. 2013;185:127.
  • Smulyan H, Mookherjee S, Safar ME. The two faces of hypertension: role of aortic stiffness. J Am Soc Hypertens. 2016;10:175–83.
  • Flett AS, Maestrini V, Milliken D, Fontana M, Treibel TA, Harb R, Sado DM, Quarta G, Herrey A, Sneddon J, et al. Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy. Int J Cardiol. 2015;183:143–48.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.